Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
165.20M | 229.92M | 220.85M | 275.11M | 218.75M | 441.85M | Gross Profit |
19.73M | 4.42M | 13.82M | 22.86M | -30.62M | 51.15M | EBIT |
3.33M | -11.95M | 2.25M | 9.96M | -45.85M | 34.18M | EBITDA |
3.95M | -8.61M | 3.03M | 10.77M | -37.40M | 38.89M | Net Income Common Stockholders |
5.17M | -9.32M | 5.21M | 10.14M | -39.95M | 30.86M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
112.87M | 123.95M | 165.12M | 126.68M | 183.49M | 167.08M | Total Assets |
211.50M | 248.93M | 268.14M | 245.10M | 284.25M | 330.93M | Total Debt |
62.00K | 123.00K | 0.00 | 0.00 | 53.00K | 53.00K | Net Debt |
-48.10M | -123.83M | -142.94M | -125.75M | -183.44M | -167.03M | Total Liabilities |
34.90M | 61.83M | 71.72M | 53.88M | 63.18M | 69.92M | Stockholders Equity |
176.60M | 187.10M | 196.42M | 191.21M | 221.07M | 261.01M |
Cash Flow | Free Cash Flow | ||||
-14.60M | -28.22M | 38.40M | 7.38M | 7.09M | 4.42M | Operating Cash Flow |
-14.01M | -27.82M | 39.87M | 7.75M | 7.16M | 19.69M | Investing Cash Flow |
-68.27M | 8.95M | -22.68M | -25.50M | 9.30M | -21.70M | Financing Cash Flow |
-128.00K | -125.00K | -39.99M | -39.99M | -53.00K | 86.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $63.39B | 6.46 | 14.62% | 4.75% | 1.21% | 2.15% | |
70 Outperform | HK$1.67B | 4.35 | 21.87% | 3.21% | 11.66% | 16.73% | |
66 Neutral | $4.44B | 12.06 | 5.34% | 6.22% | 4.17% | -11.81% | |
44 Neutral | HK$644.80M | 125.30 | 2.97% | ― | -28.42% | ― | |
30 Underperform | €175.69M | ― | -238.71% | ― | -43.49% | 31.62% |